Patent · US Active

Vaccine composition comprising an antigen and a peptide having adjuvant properties

US8361476B2 · kind B2 · utility

2Cited by

3References

5Claims

0Family size

Assignee

Intercell AG · AT

Inventors

Jörg Fritz · Wien, AT
Frank Mattner · Wien, AT
Wolfgang Zauner · Wien, AT
Eszter Nagy · Wien, AT
Michael Buschle · Perchtoldsdorf, AT

Key dates

Filing date	Oct 18, 2001
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Sep 26, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.